James Gannon
 |
 |
| Affiliation: | GNSO, ICANN |
| Stakeholder Group(s): | ,|xyz|xyz| }} |
| Region: | Europe |
| Country: | Ireland |
| Email: | james [at] cyberinvasion.net |
| Website: | |
| LinkedIn: |  James Gannon
|
| Twitter: |  @cyberinvasion
|
James Gannon is Director of Technology Quality for Novartis AG a global healthcare and pharmaceutical company. Involved in ICANN for a number of years focused on security and governance activities, he has previously served on the Customer Standing Committee, the Second Security, Stability and Resilience Review Team and as a member of the GNSO Council.
He was highly involved in the IANA transition in both with the CWG and the CCWG work streams. He is currently a member of the PTI Board of Directors appointed for a 3 year term by the 2020 Nominating Committee.
His background includes time as a Chief Information Security Officer for a Digital Health firm in Washington DC and time as a Security Consultant in both Washington DC and Basel, Switzerland.
Coming from an engineering background he quickly found his calling working to secure companies operating in the medial and biotech spaces. He has worked extensively with startups based in the US to build security and privacy programs from the ground up. He has extensive background working with regulators including the FDA, IMB and various European medical authorities to bring security to the processes and devices that are used to save lives and help prevent suffering across the world.
Mr. Gannon serves on the advisory board to ENISA (European Network and Information Security Agency) specializing in the areas of medical device security and industrial control systems and high end manufacturing systems security.
He has recently been working heavily on Internet Governance matters with a focus on Privacy and Security in ICANN as a member of the Non Commercial Users Constituency (NCUC)
His first face to face meeting was the CWG and CCWG meetings in Istanbul and his first ICANN meeting was ICANN53 in Buenos Aires.